BOHRF Original Authors' Main Conclusions
The original authors' main conclusions are taken from Abstract, Results and
Discussion. They are decided upon by the authors of the BOHRF occupational
asthma guidelines and form part of the guidelines.
Subjects were given anti-asthmatics, recommended to avoid exposure to Toluene di-isocyanate (TDI), and were monitored for 2 years (mean follow-up 12 months). 17/35 recovered completely, 11 showed significant improvement and 7 remained stable. No effect of age or exposure duration or specific IGE was noted. Favourable prognosis was associated with short duration of asthmatic symptoms before diagnosis, immediate cessation of exposure after diagnosis, milder degree of airway hyper-responsiveness, and the presence of specific IgE antibodies to TDI-human serum albumin conjugate.
This page is showing the information from the BOHRF occupational asthma guidelines for this reference. To see additional information, including opinions left by users of this website please view the full reference. This page allows users to comment on the reference and suggest it as evidence for questions. These may be the existing questions from the Bohrf occupational asthma guidelines or questions that have been put forward by users of this website.